Baronsmead VCT 2 PLC
28 March 2000
Baronsmead VCT 2 plc
'Baronsmead VCT 2 plc announces that its offer of 12 million New Ordinary
Shares ('the Offer') has been fully subscribed.
The Board recognises that there has been demand for the Offer in excess of 12
million New Ordinary Shares and, having reviewed the Company's prospects for
future investment, is offering, on the same terms, a further 3,650,000 New
Ordinary Shares representing approximately 10% of those issued and to be
issued under the Offers. Existing subscription forms remain valid for the
extended offer.
In addition, following a decrease in the net asset value since the date of the
Prospectus, in accordance with the terms and conditions of Subscription, the
Board in consultation with Noble & Company Limited have agreed to a decrease
in the Offer Price from 137 pence per New Ordinary Share to 130 pence per New
Ordinary Share (the 'Revised Offer Price') under the Offers.
The revised offer price applies to all the New Ordinary Shares, including the
New Ordinary Shares to be issued under the Offer, that are yet to be allotted.
David Thorp, Friends Ivory & Sime Private Equity plc: 0171 853 6900
Keith Hannay, Friends Ivory & Sime plc : 0131 465 1096
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.